(Q51056286)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17335406%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

editorial

0 references

title

Dry powder inhalation versus wet nebulisation delivery of antibiotics in cystic fibrosis patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17335406%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

0 references

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17335406%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Westerman EM

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17335406%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Heijerman HG

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17335406%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

English

0 references

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17335406%20AND%20SRC:MED&resulttype=core&format=json

Expert Opinion on Drug Delivery

26 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17335406%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17335406%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17335406%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

91-94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17335406%20AND%20SRC:MED&resulttype=core&format=json

Detecting early structural lung damage in cystic fibrosis.

26 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.91

Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.91

European Respiratory Society Guidelines on the use of nebulizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.91

Comparison of lung deposition of colomycin using the HaloLite and the Pari LC Plus nebulisers in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.91

A widely available method for the assessment of aerosol delivery in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.91

Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.91

Inhaled micronised gentamicin powder: a new delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.91

Dry powder inhalation of antibiotics in cystic fibrosis therapy: part 2. Inhalation of a novel colistin dry powder formulation: a feasibility study in healthy volunteers and patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.91

Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept (Twincer) for high powder doses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.91

Improved survival among young patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.2.91